Baxter International Faces Class Action Over Alleged Malfunctions of Novum LVP Devices
- Baxter International faces a class action lawsuit over undisclosed malfunctions in its Novum Large Volume Pump devices.
- Allegations include serious health risks due to device malfunctions, impacting patient safety and company reputation.
- The lawsuit questions Baxter's optimistic financial statements, raising concerns among investors about the company's future stability.
Baxter International Faces Class Action Over Alleged Device Malfunctions
Baxter International Inc. finds itself embroiled in a potential class action lawsuit that highlights serious allegations regarding its Novum Large Volume Pump (LVP) devices. The Law Offices of Frank R. Cruz recently announced an opportunity for investors who incurred losses related to Baxter’s operations to lead a securities fraud class action. The lawsuit, which stems from events between February 23, 2022, and July 30, 2025, claims that Baxter failed to disclose critical information about systemic defects in its Novum LVP devices. These defects reportedly resulted in significant malfunctions—including underinfusion, overinfusion, and non-delivery of fluids—that could expose patients to severe health risks, including injury or even death.
Central to the lawsuit is the assertion that Baxter was aware of multiple malfunctions associated with the Novum LVP devices but failed to adequately communicate these issues to customers. The complaint alleges that inadequate alerts and insufficient corrective measures allowed persistent design flaws to remain unaddressed. This negligence not only jeopardizes patient safety but also raises concerns regarding the company’s reputation in the healthcare industry, where patient trust and product reliability are paramount. As the lawsuit unfolds, there is a growing concern that the ongoing issues with the Novum LVP may force Baxter to withdraw the device from use entirely, impacting its operational capacity and future sales of these critical medical devices.
The lawsuit further claims that Baxter’s optimistic statements regarding its operations and future prospects were misleading and lacked a reasonable basis. Investors are particularly concerned about the implications of these allegations on the company’s financial health and market position. As the December 15, 2025 deadline approaches for investors wishing to participate as lead plaintiffs, affected stakeholders are urged to consider their options carefully. The Law Offices of Frank R. Cruz have opened lines of communication for potential class members to explore their rights and avenues for pursuing justice in light of these serious allegations.
In addition to the class action announcement, the situation raises broader questions about regulatory oversight and the responsibilities of medical device manufacturers in ensuring product safety. The healthcare industry is under increasing scrutiny, and incidents like those alleged against Baxter may lead to calls for more stringent regulations and better protective measures for patients.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

